Fig. 2. ( A – D ) Increasing doses of dexmedetomidine (DEX) prolonged the duration of paw withdrawal latency (PWL) to a heat stimulus when compared with the ropivacaine control group. Between-group comparisons from 90 to 210 min found multiple significant differences at individual time points. * Statistical significance, P < 0.005.